SVB Leerink reiterated coverage on Myovant Sciences with a new price target

2/16/22 5:19:55 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink reiterated coverage of Myovant Sciences with a rating of Market Perform and set a new price target of $19.00 from $21.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MYOV

Date	Price Target	Rating	Analyst
10/26/2022		Outperform → In-line	Evercore ISI
8/9/2022	$12.00 → $23.00	Mkt Perform → Outperform	SVB Leerink
2/16/2022	$21.00 → $19.00	Market Perform	SVB Leerink
1/5/2022	$23.00 → $21.00	Market Perform	SVB Leerink
10/27/2021	$24.00 → $23.00	Market Perform	SVB Leerink
9/9/2021	$24.00	Market Perform	SVB Leerink
8/20/2021	$18.00	Neutral	Goldman